Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.39 |
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
| ▸ | SI | P14410 | 1/20 | 0.39 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.39 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | MMP8 | P22894 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19270620 | 1.00 | ALDH1A1 (0.46) | ALDH1A1HSD17B10TDP1LMNACYP3A4 | |
| SCHEMBL9674559 | 0.83 | ALDH1A1 (0.43) | ALDH1A1HSD17B10TDP1LMNACYP3A4 | |
| SCHEMBL9079716 | 0.82 | ALDH1A1 (0.42) | ALDH1A1HSD17B10TDP1LMNACYP3A4 | |
| SCHEMBL13643227 | 0.81 | GAA (0.50) | ALDH1A1HSD17B10TDP1LMNACYP3A4 | |
| SCHEMBL17792657 | 0.81 | GAA (0.50) | ALDH1A1HSD17B10TDP1LMNACYP3A4 | |
| SCHEMBL1878452 | 0.81 | ALDH1A1 (0.42) | ALDH1A1HSD17B10LMNACYP3A4CYP2C19 | |
| SCHEMBL1245716 | 0.81 | GAA (0.50) | ALDH1A1HSD17B10TDP1LMNACYP3A4 | |
| SCHEMBL28739690 | 0.81 | ALDH1A1 (0.42) | ALDH1A1HSD17B10LMNACYP3A4CYP2C19 | |
| SCHEMBL13781599 | 0.79 | ALDH1A1 (0.40) | ALDH1A1HSD17B10TDP1LMNACYP3A4 | |
| SCHEMBL3998257 | 0.79 | ALDH1A1 (0.50) | ALDH1A1TDP1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240158719-A1 | METHOD FOR FRACTIONATING A SHEA EXTRACT | BIOSYNTHIS (FR) | 2024-05-16 | — | — | US | disclosed |
| US-20240140888-A1 | COMPOSITION COMPRISING AN ALKANE AND AN OXOESTER | BIOSYNTHIS (FR) | 2024-05-02 | — | — | US | disclosed |
| EP-4305134-A1 | METHOD OF FRACTIONATING A SHEA EXTRACT | Biosynthis (FR) | 2024-01-17 | — | — | EP | disclosed |
| US-11834545-B2 | Moisture-curing compositions | COVESTRO DEUTSCHLAND AG (DE) | 2023-12-05 | — | — | US | disclosed |
| US-20230382917-A1 | Heterocyclic Adenosine Receptor Antagonists | EXELIXIS, INC. | 2023-11-30 | — | — | US | disclosed |
| CN-108602785-B | Novel processes and intermediates | 诺华股份有限公司 | 2023-08-11 | — | — | CN | disclosed |
| US-11718622-B2 | Heterocyclic adenosine receptor antagonists | EXELIXIS INC. (US) | 2023-08-08 | — | — | US | disclosed |
| US-11667746-B2 | Moisture-curing compositions | COVESTRO DEUTSCHLAND AG (DE) | 2023-06-06 | — | — | US | disclosed |
| WO-2022189678-A1 | METHOD OF FRACTIONATING A SHEA EXTRACT | BIOSYNTHIS (FR) | 2022-09-15 | — | — | WO | disclosed |
| WO-2018015476-A1 | METHOD OF CONTROLLING PLANTS | SYNGENTA PARTICIPATIONS AG (CH) | 2018-01-25 | — | — | WO | disclosed |
| US-9174969-B2 | Indoline scaffold SHP-2 inhibitors and cancer treatment method | UNIVERSITY OF SOUTH FLORIDA (US) | 2015-11-03 | — | — | US | disclosed |
| EP-1730204-B1 | COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS | BASELL POLIOLEFINE SRL (IT) | 2011-08-10 | — | — | EP | disclosed |
| US-20110190315-A1 | INDOLINE SCAFFOLD SHP-2 INHIBITORS AND CANCER TREATMENT METHOD | UNIVERSITY OF SOUTH FLORIDA (US) | 2011-08-04 | — | — | US | disclosed |
| EP-2011499-A2 | Pyrrolo[2,3d]Pyrimidine compositions and their use | OSI Pharmaceuticals, Inc. (US) | 2009-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240140888-A1 | COMPOSITION COMPRISING AN ALKANE AND AN OXOESTER | ALKBH2, ABHD12, FAAH2 | ALDH1A1 938/4885HSD17B10 568/4885TDP1 2123/4885 |
| US-20230382917-A1 | Heterocyclic Adenosine Receptor Antagonists | ADORA2A, ADORA1, ADORA3 | ALDH1A1 789/4885HSD17B10 3469/4885TDP1 1947/4885 |
| US-11718622-B2 | Heterocyclic adenosine receptor antagonists | ADORA2A, ADORA1, ADORA3 | ALDH1A1 789/4885HSD17B10 3469/4885TDP1 1947/4885 |
| US-20110190315-A1 | INDOLINE SCAFFOLD SHP-2 INHIBITORS AND CANCER TREATMENT METHOD | PTPN7, PTPN3, PTPN5 | ALDH1A1 3520/4885HSD17B10 2635/4885TDP1 4018/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.